These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


370 related items for PubMed ID: 21104033

  • 1. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
    Yang Y, Li X, Yang H, Qian Y, Zhang Y, Fang R, Chen X.
    Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033
    [Abstract] [Full Text] [Related]

  • 2. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana.
    Pêra FF, Mutepfa DL, Khan AM, Els JH, Mbewana S, van Dijk AA, Rybicki EP, Hitzeroth II.
    Virol J; 2015 Dec 02; 12():205. PubMed ID: 26626122
    [Abstract] [Full Text] [Related]

  • 3. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection.
    Dong JL, Liang BG, Jin YS, Zhang WJ, Wang T.
    Virology; 2005 Sep 01; 339(2):153-63. PubMed ID: 15992851
    [Abstract] [Full Text] [Related]

  • 4. Expression and characterization of human group C rotavirus virus-like particles in insect cells.
    Clark KB, Lin SC, Humphrey C, Foytich K, Esona M, Wang Y, Liu M, Jiang B.
    Virology; 2009 May 10; 387(2):267-72. PubMed ID: 19285329
    [Abstract] [Full Text] [Related]

  • 5. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice.
    Zhou B, Zhang Y, Wang X, Dong J, Wang B, Han C, Yu J, Li D.
    Vaccine; 2010 Aug 23; 28(37):6021-7. PubMed ID: 20637305
    [Abstract] [Full Text] [Related]

  • 6. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S, Hankaniemi MM, Sioofy-Khojine AB, Laitinen OH, Hyöty H, Hytönen VP, Vesikari T, Blazevic V.
    Vaccine; 2019 Dec 03; 37(51):7509-7518. PubMed ID: 31585726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M, Cai L.
    Viral Immunol; 2001 Dec 03; 14(1):31-47. PubMed ID: 11270595
    [Abstract] [Full Text] [Related]

  • 11. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
    Malm M, Heinimäki S, Vesikari T, Blazevic V.
    Clin Exp Immunol; 2017 Sep 03; 189(3):331-341. PubMed ID: 28407442
    [Abstract] [Full Text] [Related]

  • 12. VP6: A candidate rotavirus vaccine.
    Ward RL, McNeal MM.
    J Infect Dis; 2010 Sep 01; 202 Suppl():S101-7. PubMed ID: 20684688
    [Abstract] [Full Text] [Related]

  • 13. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
    Li T, Lin H, Zhang Y, Li M, Wang D, Che Y, Zhu Y, Li S, Zhang J, Ge S, Zhao Q, Xia N.
    Vaccine; 2014 Apr 07; 32(17):1921-31. PubMed ID: 24530406
    [Abstract] [Full Text] [Related]

  • 14. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery.
    Soler E, Parez N, Passet B, Dubuquoy C, Riffault S, Pillot M, Houdebine LM, Schwartz-Cornil I.
    Vaccine; 2007 Aug 21; 25(34):6373-80. PubMed ID: 17629366
    [Abstract] [Full Text] [Related]

  • 15. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.
    Ogier A, Franco MA, Charpilienne A, Cohen J, Pothier P, Kohli E.
    Eur J Immunol; 2005 Jul 21; 35(7):2122-30. PubMed ID: 15948217
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O, Gutierrez-Xicotencatl L, Plett-Torres T, Pedroza-Saavedra A, Gonzalez-Jaimes A, Chihu-Amparan L, Maldonado-Gama M, Espino-Solis G, Bonifaz LC, Esquivel-Guadarrama F.
    Vaccine; 2015 Aug 20; 33(35):4228-37. PubMed ID: 25850020
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.